Ultrasound-Guided Core Needle Biopsy to Assess Sensitivity and Specificity of Axillary Lymph Node Metastasis in Breast Cancer

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-70
SponsorThe First Hospital of Jilin University

About this trial

This study plans to find the most suitable lymph node cortex thickness and abnormal lymph node features to define suspicious lymph nodes. Then, ultrasound-guided core needle biopsy of axillary lymph nodes will be done, aiming to provide some guidance for the biopsy.

Eligibility criteria

Qualifiers

Age ≥18 years and <70 years;

Histologically confirmed primary breast cancer;

Underwent ultrasound examination to assess axillary lymph node metastasis status.

Disqualifiers

Presence of other malignancies (e.g., lymphoma, lung cancer, thyroid cancer, etc., with axillary metastasis);

Pregnant or lactating women;

Previous receipt of neoadjuvant radiotherapy or chemotherapy;

Lymph node metastasis status not confirmed by pathology, or time interval between ultrasound examination and pathological confirmation exceeding 6 weeks.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Locations

This trial has no locations

Sponsors and collaborators

The First Hospital of Jilin University

Lead sponsor

Siping Central People's Hospital

Collaborator

Baicheng Central Hospital

Collaborator

Jilin Central General Hospital

Collaborator